🇺🇸 FDA
Pipeline program

Ixekizumab

PsO_IXE

Approved mab active

Quick answer

Ixekizumab for Plaque Psoriasis is a Approved program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Plaque Psoriasis
Phase
Approved
Modality
mab
Status
active

Clinical trials